​​FDA to al­low 23andMe to re­port more BR­CA vari­ants; Janssen se­cures deal with AI-drug dis­cov­ery out­fit

23andMe re­ceived FDA clear­ance to re­port an ad­di­tion­al 41 vari­ants in the BR­CA1 and BR­CA2 genes, which are as­so­ci­at­ed with a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.